Collegium Pharmaceutical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Collegium Pharmaceutical, Inc. (COLL) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 2.79 million shares as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2026-02-26
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2.79M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2.53M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2.24M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 1.93M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2025-12-31 | 2.79M shares 10-K · filed 2026-02-26 |
| 2024-12-31 | 2.53M shares 10-K · filed 2025-02-27 |
| 2023-12-31 | 2.24M shares 10-K · filed 2024-02-22 |
| 2022-12-31 | 1.93M shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |